AngioDynamics, Inc. (NASDAQ:ANGO) Shares Bought by Jacobs Levy Equity Management Inc.

Jacobs Levy Equity Management Inc. grew its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 26.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 521,949 shares of the medical instruments supplier's stock after purchasing an additional 107,829 shares during the period. Jacobs Levy Equity Management Inc. owned approximately 1.29% of AngioDynamics worth $4,781,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. SBI Securities Co. Ltd. purchased a new stake in shares of AngioDynamics in the 4th quarter worth about $28,000. JPMorgan Chase & Co. boosted its position in shares of AngioDynamics by 28.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 553,161 shares of the medical instruments supplier's stock worth $4,304,000 after buying an additional 123,271 shares in the last quarter. Barclays PLC boosted its position in shares of AngioDynamics by 81.0% in the 3rd quarter. Barclays PLC now owns 83,582 shares of the medical instruments supplier's stock worth $651,000 after buying an additional 37,394 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of AngioDynamics by 3.2% in the 4th quarter. Bank of New York Mellon Corp now owns 122,676 shares of the medical instruments supplier's stock worth $1,124,000 after buying an additional 3,815 shares in the last quarter. Finally, Principal Financial Group Inc. purchased a new stake in shares of AngioDynamics in the 4th quarter worth about $879,000. 89.43% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, HC Wainwright reiterated a "buy" rating and issued a $16.00 price objective (up from $15.00) on shares of AngioDynamics in a research report on Monday, April 7th.

AngioDynamics Price Performance

NASDAQ:ANGO traded up $0.01 on Tuesday, reaching $9.60. The stock had a trading volume of 24,740 shares, compared to its average volume of 552,524. The company has a market cap of $389.83 million, a price-to-earnings ratio of -1.70 and a beta of 0.58. The firm's fifty day moving average is $9.45 and its two-hundred day moving average is $9.44. AngioDynamics, Inc. has a 12-month low of $5.47 and a 12-month high of $13.50.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last released its earnings results on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.13) by $0.16. The company had revenue of $72.00 million for the quarter, compared to analyst estimates of $70.30 million. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The firm's revenue for the quarter was down 4.3% on a year-over-year basis. As a group, research analysts forecast that AngioDynamics, Inc. will post -0.37 earnings per share for the current fiscal year.

About AngioDynamics

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.